These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 10527956

  • 1. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.
    Weiss N, Feussner A, Hailer S, Spengel FA, Keller C, Wolfram G.
    Eur J Med Res; 1999 Oct 15; 4(10):425-32. PubMed ID: 10527956
    [Abstract] [Full Text] [Related]

  • 2. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
    Henning BF, Zidek W, Riezler R, Graefe U, Tepel M.
    Res Exp Med (Berl); 2001 Mar 15; 200(3):155-68. PubMed ID: 11426667
    [Abstract] [Full Text] [Related]

  • 3. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct 15; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 4. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM.
    Clin Nephrol; 1998 Apr 15; 49(4):232-5. PubMed ID: 9582553
    [Abstract] [Full Text] [Related]

  • 5. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
    Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM.
    N Engl J Med; 1998 Apr 09; 338(15):1009-15. PubMed ID: 9535664
    [Abstract] [Full Text] [Related]

  • 6. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K, Böger RH.
    Z Kardiol; 2001 Jan 09; 90(1):1-11. PubMed ID: 11220081
    [Abstract] [Full Text] [Related]

  • 7. The influence of dietary vitamin E, fat, and methionine on blood cholesterol profile, homocysteine levels, and oxidizability of low density lipoprotein in the gerbil.
    Hidiroglou N, Gilani GS, Long L, Zhao X, Madere R, Cockell K, Belonge B, Ratnayake WM, Peace R.
    J Nutr Biochem; 2004 Dec 09; 15(12):730-40. PubMed ID: 15607646
    [Abstract] [Full Text] [Related]

  • 8. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
    Malinow MR.
    Can J Cardiol; 1999 Apr 09; 15 Suppl B():31B-34B. PubMed ID: 10350683
    [Abstract] [Full Text] [Related]

  • 9. Elevated homocyst(e)ine levels with preeclampsia.
    Rajkovic A, Catalano PM, Malinow MR.
    Obstet Gynecol; 1997 Aug 09; 90(2):168-71. PubMed ID: 9241286
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr 09; 240(4):286-90. PubMed ID: 11981642
    [Abstract] [Full Text] [Related]

  • 11. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid.
    Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T.
    Clin Sci (Lond); 1999 Mar 09; 96(3):235-9. PubMed ID: 10029559
    [Abstract] [Full Text] [Related]

  • 12. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD.
    Arterioscler Thromb Vasc Biol; 1997 Nov 09; 17(11):2930-4. PubMed ID: 9409278
    [Abstract] [Full Text] [Related]

  • 13. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.
    Ubbink JB.
    J Inherit Metab Dis; 1997 Jun 09; 20(2):316-25. PubMed ID: 9211204
    [Abstract] [Full Text] [Related]

  • 14. Hyperhomocyst(e)inemia--determining factors and treatment.
    Genest J.
    Can J Cardiol; 1999 Apr 09; 15 Suppl B():35B-38B. PubMed ID: 10350684
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
    Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B, Hannedouche TP.
    Nephrol Dial Transplant; 1999 Aug 09; 14(8):1934-42. PubMed ID: 10462274
    [Abstract] [Full Text] [Related]

  • 16. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C, Torres-Tamayo M, Zamora-González J, Aguilar-Herrera BE, Posadas-Sánchez R, Cardoso-Saldaña G, Ladrón de Guevara G, Solis-Vallejo E, El Hafidi M.
    Arthritis Rheum; 2004 Jan 09; 50(1):160-5. PubMed ID: 14730612
    [Abstract] [Full Text] [Related]

  • 17. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
    Moghadasian MH, McManus BM, Frohlich JJ.
    Arch Intern Med; 1997 Nov 10; 157(20):2299-308. PubMed ID: 9361570
    [Abstract] [Full Text] [Related]

  • 18. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK, Kwon YJ, Yoon JW, Oh KS, Cha DR, Cho WY, Huh K, Pyo HJ, Kim HK.
    J Korean Med Sci; 1999 Apr 10; 14(2):193-8. PubMed ID: 10331567
    [Abstract] [Full Text] [Related]

  • 19. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease.
    Duell PB, Malinow MR.
    Curr Opin Lipidol; 1997 Feb 10; 8(1):28-34. PubMed ID: 9127708
    [Abstract] [Full Text] [Related]

  • 20. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb 10; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.